Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents

E-ISSN： 1875-533x|7|12|1189-1212

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.7, Iss.12, 2000-12, pp. : 1189-1212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Topoisomerase I-Targeting Agents, Camptothecin Analogues

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-01 ,pp. : 611-619

Bentham Science Publishers

Access to resources Recommend Favorite

Rebeccamycin analogues as anti-cancer agents

By Prudhomme M.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 123-140

Elsevier

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of the topoisomerase I inhibitors

By Seiter Karen

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 45-53

Informa Healthcare

Access to resources Recommend Favorite